Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Lepr Rev ; 75(1): 67-78, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15072128

ABSTRACT

Decentralization policies are an integrated component of health sector reform in an increasing number of countries. The ability of such policies to improve the health system's quality and efficiency is backed up by limited scientific evidence. This study intends to evaluate the impact of decentralization on a specialized field of disease control (leprosy control) in Colombia and Brazil. It analyses the respective juridical base, epidemiological indicators and local publications. Furthermore, 39 semi-structured interviews with key informants were conducted. In both countries, the devolution of technical responsibility and financial resources to the municipalities was the implemented form of decentralization. Access to preventive and curative health care and the community participation in decision-making improved clearly only in Brazil. The decentralization to private providers in Colombia had dubious effects on service quality in general and still more on public health. The flow of finances (including finance collection through state-owned taxes instead of insurance companies) seemed to be better controlled in Brazil. Leprosy control in Brazil took advantage of the decentralization process; in Colombia, it came close to a collapse.


Subject(s)
Communicable Disease Control/organization & administration , Leprosy/prevention & control , National Health Programs/standards , Politics , Brazil/epidemiology , Colombia/epidemiology , Female , Health Care Reform , Humans , Leprosy/epidemiology , Local Government , Male , National Health Programs/trends , Outcome Assessment, Health Care , Policy Making , Risk Assessment
2.
J Am Acad Dermatol ; 49(2 Suppl Case Reports): S170-3, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12894113

ABSTRACT

We describe a 58-year-old man presenting with necrotizing panniculitis of the lower right leg and a 64-year-old woman with a clinically similar lesion combined with pustular eruptions and subsequent ulceration on the forehead. In the first patient, Giemsa staining showed small ovoid bodies and Grocott staining revealed hyphae. Histology from the process on the forehead showed branched filaments in the periodic acid-Schiff (PAS) staining. In the first case, Madurella mycetomatis, a fungus, was the pathogenic agent, whereas in the other case white colonies of filamentous organisms resembling fungi could be cultivated that turned out to be the bacterium Nocardia brasiliensis. Since the initial clinical appearance of these two forms of mycetoma were almost identical and histopathologic findings were inconclusive, only sophisticated microbiologic work-up of material from lesional skin led to the correct diagnosis. In times of global tourism, these unusual cases impressively document the necessity to become more familiar with mycetoma to make accurate therapeutic decisions with effective results, possibly saving a limb.


Subject(s)
Dermatomycoses/diagnosis , Madurella/isolation & purification , Mycetoma/diagnosis , Panniculitis/pathology , Antifungal Agents/administration & dosage , Biopsy, Needle , Combined Modality Therapy , Dermatomycoses/therapy , Diagnosis, Differential , Facial Dermatoses/microbiology , Facial Dermatoses/therapy , Female , Follow-Up Studies , Humans , Immunohistochemistry , Lower Extremity , Male , Middle Aged , Mycetoma/therapy , Necrosis , Panniculitis/microbiology , Risk Assessment , Severity of Illness Index , Surgical Procedures, Operative/methods , Treatment Outcome
3.
Clin Infect Dis ; 37(2): e19-21, 2003 Jul 15.
Article in English | MEDLINE | ID: mdl-12856229

ABSTRACT

Murray Valley encephalitis (MVE) is an important mosquitoborne flavivirus infection endemic to Australia and Papua New Guinea. We report the first imported case of MVE in Europe. A 23-year-old tourist developed severe encephalitis after having returned to Germany from a long-term trip across the Australian continent. The diagnosis was suspected on the basis of clinical findings and the patient's travel history and was confirmed by serological findings. The patient made a prolonged but complete recovery. Our case coincides with a recently reported spread of MVE virus in Australia. This emphasizes the need for continuous surveillance in areas of endemicity and appropriate protection when traveling through regions in which the MVE virus is endemic.


Subject(s)
Encephalitis Virus, Murray Valley , Encephalitis, Arbovirus/transmission , Adult , Antiviral Agents/therapeutic use , Australia/epidemiology , Encephalitis, Arbovirus/drug therapy , Encephalitis, Arbovirus/epidemiology , Encephalitis, Arbovirus/immunology , Germany/epidemiology , Humans , Male , Papua New Guinea/epidemiology , Travel
4.
Clin Infect Dis ; 36(10): 1254-8, 2003 May 15.
Article in English | MEDLINE | ID: mdl-12746770

ABSTRACT

This study sought to assess the risk of secondary transmission after import of Lassa fever into Europe. A total of 232 persons exposed to a case of Lassa fever imported into Germany were identified. The level of exposure was determined for 157 persons (68%), and 149 (64%) were tested serologically. High-risk or close contact was reported by 30 (19%) of 157 persons. No symptomatic secondary infections were observed. However, Lassa virus-specific immunoglobulin G antibodies were detected in a serum sample obtained from a physician who examined the index patient on day 9 of illness. The physician received ribavirin prophylaxis and did not develop symptoms of Lassa fever. On the basis of these data, the contact was classified as having a probable secondary infection. The study indicates a low risk of transmission during the initial phase of symptomatic Lassa fever, even with high-risk exposures. The risk may increase with progression of disease and increasing virus load.


Subject(s)
Antibodies, Viral/immunology , Lassa Fever/transmission , Lassa virus/immunology , Animals , Antiviral Agents/therapeutic use , Chemoprevention , Germany/epidemiology , Humans , Immunoglobulin G/immunology , Lassa Fever/epidemiology , Lassa Fever/immunology , Lassa Fever/prevention & control , Lassa virus/drug effects , Ribavirin/therapeutic use , Risk Management
6.
Trans R Soc Trop Med Hyg ; 96(2): 178-9, 2002.
Article in English | MEDLINE | ID: mdl-12055809

ABSTRACT

Tanapox is a rare pox disease endemic in East Africa. We report the first case of tanapox in a European traveller who contracted the disease in 1999 during a short visit to Tanzania. The diagnosis was made on clinical grounds and confirmed by electron microscopy and a tanapox virus-specific PCR assay.


Subject(s)
Poxviridae Infections/diagnosis , Skin Diseases, Viral/diagnosis , Tumor Virus Infections/diagnosis , Yatapoxvirus , Europe , Humans , Male , Middle Aged , Polymerase Chain Reaction/methods , Travel
7.
Microbes Infect ; 4(1): 43-50, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11825774

ABSTRACT

During 2000, four cases of fatal Lassa fever were imported from Africa to Europe. In two patients, consecutive serum samples were available for monitoring of virus load and cytokine levels in addition to standard laboratory data. Both patients had non-specific early clinical symptoms including high fever. Patient 1 developed multi-organ failure and died of hemorrhagic shock on day 15 of illness, while patient 2 died of respiratory failure due to aspiration without hemorrhage on day 16. Ribavirin was administered to both patients beginning only on day 11. High serum aspartate aminotransferase and lactate dehydrogenase (LDH) levels were remarkable in both patients. Patient 1 had an initial virus load of 10(6) S RNA copies/ml as measured by real-time RT-PCR. Viremia increased steadily and reached a plateau of approximately 10(8)-10(9) copies/ml 4 days before death, while IFN-gamma and TNF-alpha rose to extremely high levels only shortly before death. In contrast, in patient 2 the virus load decreased from 10(7) to 10(6) copies/ml during the late stage of illness which was paralleled by a decrease in the IFN-gamma and TNF-alpha levels. The IL-10 level increased when specific IgM and IgG appeared. These data suggest that a high virus load and high levels of pro-inflammatory cytokines in the late stage of Lassa fever play an important role in the pathogenesis of hemorrhage, multi-organ failure, and shock in Lassa fever.


Subject(s)
Lassa Fever/physiopathology , Lassa Fever/virology , Lassa virus , Adult , Africa , Antibodies, Viral/blood , Antiviral Agents/therapeutic use , Cytokines/metabolism , Fatal Outcome , Female , Humans , Lassa Fever/diagnosis , Lassa Fever/drug therapy , Lassa virus/genetics , Lassa virus/isolation & purification , Lassa virus/physiology , Male , Middle Aged , RNA, Viral/blood , Ribavirin/therapeutic use , Travel , Viral Load , Viremia
SELECTION OF CITATIONS
SEARCH DETAIL
...